Skip to main content
Equibles

Edward Dulac

CFO

Fate Therapeutics Inc (FATE)

CFO

Intellia Therapeutics, Inc. (NTLA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Edward Dulac

Edward Dulac is recorded as CFO at Fate Therapeutics Inc (FATE) and CFO at Intellia Therapeutics, Inc. (NTLA). Intellia Therapeutics, Inc. reported in an 8-K filed June 26, 2024 that Edward Dulac was appointed Executive Vice President and Chief Financial Officer, effective July 22, 2024. Edward Dulac has spoken on 3 earnings calls and 1 other investor event across 2 companies, most recently for Intellia Therapeutics, Inc. on September 14, 2026.

“On June 26, 2024, Intellia Therapeutics, Inc. (the "Company") announced the appointment, effective July 22, 2024 ("Start Date"), of Edward Dulac to serve as Executive Vice President and Chief Financial Officer ("CFO"), treasurer and principal financial officer of the Company.”
Intellia Therapeutics, Inc. Form 8-K, filed June 26, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Intellia Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Fate Therapeutics Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.